PREventing Progression of Adipose Tissue Redistribution
NCT00389194
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
120
Enrollment
OTHER
Sponsor class
Conditions
HIV Infections
Interventions
DRUG:
continuing AZT+3TC or switching AZT+3TC to TDF+ FTC
Sponsor
International Antiviral Therapy Evaluation Center
Collaborators
[object Object]